COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
[HTML][HTML] An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
[HTML][HTML] Drugs for COVID-19: An update
J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
[HTML][HTML] Pharmacological treatments of COVID-19
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …
which was reported for the first time in December 2019, was named by the World Health …
Advances in the possible treatment of COVID-19: A review.
P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019
A Barlow, KM Landolf, B Barlow… - … : The Journal of …, 2020 - Wiley Online Library
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
[HTML][HTML] The rationale for potential pharmacotherapy of COVID-19
On 11 March 2020, the coronavirus disease (COVID-19) was defined by the World Health
Organization as a pandemic. Severe acute respiratory syndrome-2 (SARS-CoV-2) is the …
Organization as a pandemic. Severe acute respiratory syndrome-2 (SARS-CoV-2) is the …
[HTML][HTML] Clinical management of COVID-19: a review of pharmacological treatment options
AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …
2020, concerted efforts have been applied by the scientific community to curtail the spread of …
Current drugs with potential for treatment of COVID-19: A literature review: Drugs for the treatment process of COVID-19
MII Rabby - Journal of pharmacy & pharmaceutical …, 2020 - journals.library.ualberta.ca
Purpose: SARS-CoV-2 first emerged in China in December 2019 and rapidly spread
worldwide. No vaccine or approved drug is available to eradicate the virus, however, some …
worldwide. No vaccine or approved drug is available to eradicate the virus, however, some …
[HTML][HTML] Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development
SARS-CoV-2 has been marked as a highly pathogenic coronavirus of COVID-19 disease
into the human population, causing over 5.5 million confirmed cases worldwide. As COVID …
into the human population, causing over 5.5 million confirmed cases worldwide. As COVID …